$QBIO In addition to the work the Company has been doing in its core markets, QBIO has also announced a key financing and restructuring of debt. Corin stated: “Q BioMed Inc. has been around roughly five years and I am thrilled with the progress that we have made over those years. We are now in a revenue generating state. We are looking at our next steps with regards to commercialization of our Strontium89 drug coupled with our desire to list on the NASDAQ as quickly as possible. Making this the right time to work on our balance sheet and eliminate as much debt as possible. We worked with a trusted partner and converted out about $4,000,000 of debt into equity. This also allowed to fund our current operations and pipeline of key assets.”
Please visit
http://www.QBioMed.com and sign up for regular updates.
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!